MCID: CPL002
MIFTS: 19

Capillary Lymphangioma

Categories: Immune diseases, Skin diseases, Cardiovascular diseases, Cancer diseases

Aliases & Classifications for Capillary Lymphangioma

MalaCards integrated aliases for Capillary Lymphangioma:

Name: Capillary Lymphangioma 12 14 69
Cutaneous Lymphangioma 12
Lymphangioma of Skin 69

Classifications:



External Ids:

Disease Ontology 12 DOID:2286
NCIt 46 C27509
SNOMED-CT 64 445492005

Summaries for Capillary Lymphangioma

MalaCards based summary : Capillary Lymphangioma, also known as cutaneous lymphangioma, is related to microcystic lymphatic malformation and glossitis. An important gene associated with Capillary Lymphangioma is PROX1 (Prospero Homeobox 1). The drugs Everolimus and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include skin and tongue.

Related Diseases for Capillary Lymphangioma

Diseases related to Capillary Lymphangioma via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 microcystic lymphatic malformation 11.4
2 glossitis 9.8
3 lymphangioma 9.8
4 angiokeratoma of fordyce 9.6 HBA1 PROX1
5 interstitial emphysema 9.5 HBA1 PROX1
6 hemangioma 9.5 LYVE1 PROX1
7 skin hemangioma 9.4 HBA1 PROX1
8 acquired hemangioma 9.2 HBA1 LYVE1 PROX1
9 lymphangiosarcoma 9.2 HBA1 LYVE1 PROX1

Graphical network of the top 20 diseases related to Capillary Lymphangioma:



Diseases related to Capillary Lymphangioma

Symptoms & Phenotypes for Capillary Lymphangioma

Drugs & Therapeutics for Capillary Lymphangioma

Drugs for Capillary Lymphangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 2 159351-69-6 6442177
2
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
3
Sirolimus Approved, Investigational Phase 2 53123-88-9 46835353 6436030 5284616
4 Anti-Bacterial Agents Phase 2
5 Antibiotics, Antitubercular Phase 2
6 Antifungal Agents Phase 2
7 Anti-Infective Agents Phase 2
8 Immunosuppressive Agents Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies Active, not recruiting NCT00975819 Phase 2 sirolimus

Search NIH Clinical Center for Capillary Lymphangioma

Genetic Tests for Capillary Lymphangioma

Anatomical Context for Capillary Lymphangioma

MalaCards organs/tissues related to Capillary Lymphangioma:

38
Skin, Tongue

Publications for Capillary Lymphangioma

Articles related to Capillary Lymphangioma:

# Title Authors Year
1
Capillary lymphangioma of the tongue complicated by glossitis. ( 13753050 )
1961

Variations for Capillary Lymphangioma

Expression for Capillary Lymphangioma

Search GEO for disease gene expression data for Capillary Lymphangioma.

Pathways for Capillary Lymphangioma

GO Terms for Capillary Lymphangioma

Sources for Capillary Lymphangioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....